Chronic Pelvic Pain Syndrome, Pelvic Floor; Relaxation, Breathing Exercises, Women
Conditions
Keywords
Women with Chronic Pelvic Pain, Breathing Exercises, Pelvic Floor Exercises
Brief summary
The primary cause of the complex interaction of chronic pelvic pain originates from the visceral organs in the pelvic cavity, and it has been observed that musculoskeletal dysfunctions (such as increased muscle activity in the pelvic floor muscles) are often accompanied by visceral painful stimuli in the pelvic region as a result of shared innervation and visceral-somatic convergence. This study aims to investigate the effect of breathing exercises combined with pelvic floor exercises on pain, pelvic floor muscle activity, psychological factors, and quality of life in women with chronic pelvic pain.
Interventions
Diaphragmatic breathing exercises with a physiotherapist for 8 weeks, two days a week
Pelvic floor exercises with a physiotherapist for 8 weeks, two days a week
Sponsors
Study design
Eligibility
Inclusion criteria
* Be diagnosed with chronic pelvic pain (CPA) * Having pelvic pain for at least 6 months * 18-45 years old * Having high resting activity of the pelvic floor (\>2 microvolts based on superficial EMG (sEMG) readings)
Exclusion criteria
* Having a history of pelvic cancer and/or surgery * Receiving radiotherapy and/or chemotherapy * Having a neurological and/or psychiatric pathology * Have a urinary tract infection * Menopause * Presence of current pregnancy status * History of miscarriage and ectopic pregnancy * Presence of prolapse * Being \>30 kg/cm2 according to body mass index (BMI) * Have received treatment for the pelvic area including manual therapy and electrotherapy in the last 6 months * Having had botulinum toxin injections in the pelvic region in the last 6 months * Having a communication problem
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Change from Baseline Pelvic Floor Muscle Activity (PFMA) at 8 weeks | at the baseline and end of the 8 weeks (16 sessions) | PFMA measurement will be performed with the sEMG NeuroTrac MyoPlus Pro (Verity Medical Ltd, UK) device integrated with computer software for digital analysis and report generation. |
| Change from Baseline Visual Analogue Scale (VAS) at 8 weeks | at the baseline and end of the 8 weeks (16 sessions) | Pain severity will be evaluated with the VAS. |
| Change from Baseline McGill Pain Scale- Short Form at 8 weeks | at the baseline and end of the 8 weeks (16 sessions) | The scale consists of 3 parts. In the first part of the scale, a total of 3 pain scores are obtained: sensory pain score, perceptual pain score and total pain score. In the second part, there were five word groups ranging from mild pain to unbearable pain to determine the severity of the patient's pain. In the third part, the current pain intensity of the patient was evaluated using a visual comparison scale. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Short Form-36 | at the baseline and end of the 8 weeks | Evaluation of quality of life |
| Global Pelvic Floor Disorder Questionnaire | at the baseline and end of the 8 weeks | Global pelvic floor disorders will be evaluated at baseline and after 8 weeks |
| Depression, Anxiety and Stress Scale | at the baseline and end of the 8 weeks | Evaluation of moods (depression, anxiety and stress) |
| Corbin Postural Rating Scale | at the baseline and end of the 8 weeks | Measuring of posture changes |
| Pelvic Pain Impact Questionnaire | at the baseline and end of the 8 weeks | Clinical evaluation of pelvic pain effect |
Countries
Turkey (Türkiye)